Is There a Relationship Between Androgenic Alopecia and Benign Prostatic Hyperplasia?

    Ladan Dastgheib, Mehdi Shirazi, Iman Moezzi, Saber Dehghan, Maryam Sadat Sadati
    Image of study
    TLDR There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.
    In 2014, a cross-sectional study was conducted on 150 men over 50 years old to evaluate the relationship between androgenic alopecia (a type of hair loss) and benign prostatic hyperplasia (BPH), both of which are androgen-dependent processes influenced by the 5-alpha reductase enzyme. The study assessed the participants' urinary symptoms, PSA level, prostate volume, and alopecia grading using the Hamilton-Norwood classification. The results showed that 59.6% of men had mild alopecia, 34.1% had moderate alopecia, and 6.3% had severe alopecia. The mean PSA level was 1.37 ± 1.48 ng/ml, the mean prostate volume was 37.85 ± 21.85cc, and the mean international prostate symptom score (IPSS) was 7.6 ± 6.11. However, the study found no relationship between these parameters and androgenic alopecia. The occurrence of alopecia at a younger age and a positive family history were correlated with a higher grade of alopecia.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 1000+ results
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 7 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  40 upvotes 5 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

    Related Research

    2 / 2 results